Creative Medical Technology Holdings (CELZ) Gross Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has reported Gross Margin for 9 consecutive years, with 66.87% the latest figure, recorded in Q4 2025.

• On a quarterly basis, Gross Margin rose 687.0% year-over-year to 66.87% in Q4 2025; TTM through Jun 2026 was 66.87%, a 687.0% increase from a year earlier, with the FY2025 full-year figure at 63.43%, up 343.0% from the prior year.
• Gross Margin was 66.87% for Q4 2025 at Creative Medical Technology Holdings, up from 60.0% in the prior quarter.
• Over five years, Gross Margin peaked at 70.91% in Q3 2022 and troughed at 41.78% in Q4 2021.
• A 5-year average of 59.89% and a median of 60.0% in 2021 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin slumped 1714 bps in 2021 and jumped 2758 bps in 2022, its largest moves.
• Over 5 years, Gross Margin stood at 41.78% in 2021, then soared by 66 bps to 69.35% in 2022, then fell by 13 bps to 60.0% in 2023, then changed by 0 bps to 60.0% in 2024, then grew by 11 bps to 66.87% in 2025.
• The last three Gross Margin figures came in at 66.87% (Q4 2025), 60.0% (Q1 2025), and 60.0% (Q4 2024), per Business Quant data.